Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (257)	10/13/1998 11:54:00 AM
From: scaram(o)uche	Read Replies (2) \| Respond to of 3044

>> Both MTC and Bayer have simply whopping committments to MLNM, I just dont see much disrupting this. << That's why I said knee "jerk". :-) >> A Bayer/MTC combo may have too many regulatory hurdles to clear. << That thought occurred to me as well, but I don't know if there are important areas of overlap. I do know that there are areas of synergy..... nice ones. >> No way a DD/MTC merger would fly. << Why? >> Can you explain what you mean by...." That would mean that a cox-2 inhibitor is back on the market."? << Just that Monsanto will still be up for grabs, and that AHP is now shut out........ that it's back to status quo.... Merck versus Searle.